Aging stem cells, latexin, and longevity

Experimental Cell Research

Volumn 314, Issue 9, 2008, Pages 1962-1972

  Liang, Ying ^a,b   Van Zant, Gary ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aging; Amyloidoses; Cancer; Latexin; Longevity; Stem cells

Indexed keywords

CYSTATIN C; LATEXIN; NERVE PROTEIN;

APOPTOSIS; CELL AGING; CELL COUNT; CELL DAMAGE; CELL DIVISION; LONGEVITY; NEOPLASM; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN LOCALIZATION; REVIEW; STEM CELL; TELOMERE;

EID: 43049173167     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.01.032     Document Type: Review

References (155)

1. A. Maximow Der Lymphozyt als gemeinsame Stammzelle der verschiedenen Blutelemente in der embryonalen Entwicklung und im postfetalen Leben der Saugetiere Folia Haematol. 8 1909 125 134
2. S. Massberg P. Schaerli I. Knezevic-Maramica M. Kollnberger N. Tubo E.A. Moseman I.V. Huff T. Junt A.J. Wagers I.B. Mazo U.H. von Andrian Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues Cell 131 2007 994 1008
3. K. Takahashi K. Tanabe M. Ohnuki M. Narita T. Ichisaka K. Tomoda S. Yamanaka Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
4. J. Yu M.A. Vodyanik K. Smuga-Otto J. Antosiewicz-Bourget J.L. Frane S. Tian J. Nie G.A. Jonsdottir V. Ruotti R. Stewart I.I. Slukvin J.A. Thomson Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
5. D.L. Jones A.J. Wagers No place like home: anatomy and function of the stem cell niche Nat. Rev. Mol. Cell Biol. 9 2008 11 21
6. A. Gosain L.A. DiPietro Aging and wound healing World J. Surg. 28 2004 321 326
7. S.M. Malik The impact of aging on chemotherapy Clin. Lung Cancer 5 2004 243 244
8. E. Henckaerts J.C. Langer J. Orenstein H.W. Snoeck The positive regulatory effect of TGF-beta2 on primitive murine hemopoietic stem and progenitor cells is dependent on age, genetic background, and serum factors J. Immunol. 173 2004 2486 2493
9. L.G. Smith I.L. Weissman S. Heimfeld Clonal analysis of hematopoietic stem-cell differentiation in vivo Proc. Natl. Acad. Sci. U. S. A. 88 1991 2788 2792
10. M. Osawa K.-i. Hanada H. Hamada H. Nakauchi Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell Science 273 1996 242 245
11. G.J. Spangrude D.M. Brooks D.B. Tumas Long-term repopulation of irradiated mice with limiting numbers of purified hematopoietic stem cells: in vivo expansion of stem cell phenotype but not function Blood 85 1995 1006 1016
12. K. Sudo H. Ema Y. Morita H. Nakauchi Age-associated characteristics of murine hematopoietic stem cells J. Exp. Med. 192 2000 1273 1280
13. F. Offner T. Kerre M. DeSmedt J. Plum Bone marrow CD34+ cells generate fewer T cells in vitro with increasing age and following chemotherapy Br. J. Haematol. 104 1999 801 808
14. Y. Liang G. Van Zant Genetic control of stem-cell properties and stem cells in aging Curr. Opin. Hematol. 10 2003 195 202
15. Y. Matsuzaki K. Kinjo R.C. Mulligan H. Okano Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells Immunity 20 2004 87 93
16. P. Benveniste C. Cantin D. Hyam N.N. Iscove Hematopoietic stem cells engraft in mice with absolute efficiency Nat. Immunol. 4 2003 708 713
17. S.J. Morrison A.M. Wandycz K. Akashi A. Globerson I.L. Weissman The aging of hematopoietic stem cells Nat. Med. 2 1996 1011 1016
18. Y. Liang G. Van Zant S.J. Szilvassy Effects of aging on the homing and engraftment of murine hematopoietic stem and progenitor cells Blood 106 2005 1479 1487
19. E. Ross N. Anderson H.S. Micklem Serial depletion and regeneration of the murine hematopoietic system. Implications for hematopoietic organization and the study of cellular aging J. Exp. Med. 155 1982 432 444
20. D.A. Ogden H.S. Mickliem The fate of serially transplanted bone marrow cell populations from young and old donors Transplantation 22 1976 287 293
21. H.S. Micklem C.E. Ford E.P. Evans D.A. Ogden D.S. Papworth Competitive in vivo proliferation of foetal and adult hematopoietic cells in lethally irradiated mice J. Cell. Physiol. 79 1972 293 298
22. V.I. Rebel C.L. Miller C.J. Eaves P.M. Lansdorp The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their adult bone marrow counterparts Blood 87 1996 3500 3507
23. L. Siminovitch J.E. Till E.A. McCulloch Decline in colony-forming ability of marrow cells subjected to serial transplantation into irradiated mice J. Cell Comp. Physiol. 64 1964 23 31
24. D.A. Ogden H.S. Micklem The fate of serially transplanted bone marrow cell populations from young and old donors Transplantation 22 1976 287 293
25. N. Iscove K. Nawa Hematopoietic stem cells expand during serial transplantation in vivo without apparent exhaustion Curr. Biol. 7 1997 805 808
26. D.E. Harrison C.M. Astle J.A. Delaittre Loss of proliferative capacity in immunohemopoietic stem cells is caused by serial transplantation rather than aging J. Exp. Med. 147 1978 1526 1531
27. R.J. Harstock S.E. C.S. Ketter Normal variation with aging of the amount of hematopoietic tissue in bone marrow from anterior iliac crest Am. J. Clin. Pathol. 43 1965 325 333
28. G.P. Bagnara L. Bonsi P. Strippoli F. Bonifazi R. Tonelli S. D'Addato R. Paganelli E. Scala U. Fagiolo D. Monti A. Cossarizza M. Bonafe C. Franceschi Hemopoiesis in healthy old people and centenarians: well-maintained responsiveness of CD34+ cells to hemopoietic growth factors and remodeling of cytokine network J. Gerontol. A Biol. Sci. Med. Sci. 55 2000 B61 B66 discussion B67–70
29. A. Waterstrat E.J. Oakley A. Miller C. Swiderski Y. Liang G. Van Zant Mechanisms of stem cell aging K.L. Rudolph “Telomeres and Telomerase in Ageing, Disease, and Cancer” 2008 Springer-Verlag Berlin
30. T.A. Rando Stem cells, ageing and the quest for immortality Nature 441 2006 1080 1086
31. G. Van Zant B.P. Holland P.W. Eldridge J.-J. Chen Genotype-restricted growth and aging patterns in hematopoietic stem cell populations of allophenic mice J. Exp. Med. 171 1990 1547 1565
32. D. Schlessinger G. Van Zant Does functional depletion of stem cells drive aging? Mech. Ageing Dev. 122 2001 1537 1553
33. N.E. Sharpless R.A. DePinho How stem cells age and why this makes us grow old Nat. Rev. Mol. Cell Biol. 8 2007 703 713
34. G. Van Zant K. Scott-Micus B.P. Thompson R.A. Fleischman S. Perkins Stem cell quiescence/activation is reversible by serial transplantation and is independent of stromal cell genotype in mouse aggregation chimeras Exp. Hematol. 20 1992 470 475
35. S.J. Morrison A.M. Wandycz K. Akashi A. Globerson I.L. Weissman The aging of hematopoietic stem cells Nature Med. 2 1996 1011 1016
36. M. Kim H.B. Moon G.J. Spangrude Major age-related changes of mouse hematopoietic stem/progenitor cells Ann. N. Y. Acad. Sci. 996 2003 195 208
37. S.D. Tyner S. Venkatachalam J. Choi S. Jones N. Ghebranious H. Igelmann X. Lu G. Soron B. Cooper C. Brayton S. Hee Park T. Thompson G. Karsenty A. Bradley L.A. Donehower p53 mutant mice that display early ageing-associated phenotypes Nature 415 2002 45 53
38. L.A. Donehower Does p53 affect organismal aging? J. Cell. Physiol. 192 2002 23 33
39. M. Dumble L. Moore S.M. Chambers H. Geiger G. Van Zant M.A. Goodell L.A. Donehower The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging Blood 109 2007 1736 1742
40. J. Domen S.H. Cheshier I.L. Weissman The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of BCL-2 increases both their number and repopulation potential J. Exp. Med. 191 2000 253 263
41. I.L. Weissman Stem cells: Units of development, units of regeneration, and units in evolution Cell 100 2000 157 168
42. S.J. Morrison N. Uchida I.L. Weissman The biology of hematopoietic stem cells Annu. Rev. Cell Dev. Biol. 11 1995 35 71
43. G.B. Bradford B. Williams R. Rossi I. Bertoncello Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment Exp. Hematol. 25 1997 445 453
44. S.H. Cheshier S.J. Morrison X. Liao I.L. Weissman In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells Proc. Natl. Acad. Sci. U. S. A. 96 1999 3120 3125
45. H.E.M. Kay How many cell-generations? Lancet ii 1965 418
46. T. Finkel M. Serrano M.A. Blasco The common biology of cancer and ageing Nature 448 2007 767 774
47. R.B. Effros A. Globerson Hematopoietic cells and replicative senescence Exp. Gerontol. 37 2002 191 196
48. Y. Liu H. Kha M. Ungrin M.O. Robinson L. Harrington Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert Proc. Natl. Acad. Sci. U. S. A. 99 2002 3597 3602
49. T.H. Brummendorf J. Mak K.M. Sabo G.M. Baerlocher K. Dietz J.L. Abkowitz P.M. Lansdorp Longitudinal studies of telomere length in feline blood cells: implications for hematopoietic stem cell turnover in vivo Exp. Hematol. 30 2002 1147 1152
50. J. Campisi S. Kim C.S. Lim M. Rubio Cellular senescence, cancer and aging: the telomere connection Exp. Gerontol. 36 2001 1619 1637
51. J.W. Shay W.E. Wright When do telomeres matter? Science 291 2001 839 840
52. A. Satyanarayana S.U. Wiemann J. Buer J. Lauber K.E. Dittmar T. Wustefeld M.A. Blasco M.P. Manns K.L. Rudolph Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells Embo J. 22 2003 4003 4013
53. J. Campisi Cancer and ageing: rival demons? Nat. Rev. Cancer 3 2003 339 349
54. H. Vaziri W. Dragowska R.C. Allsopp T.E. Thomas C.B. Harley P.M. Lansdorp Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age Proc. Natl. Acad. Sci. U. S. A. 91 1994 9857 9860
55. S.J. Morrison K.R. Prowse P. Ho I.L. Weissman Telomerase activity in hematopoietic cells is associated with self-renewal potential Immunity 5 1996 207 216
56. J. Yui C.P. Chiu P.M. Lansdorp Telomerase activity in candidate stem cells from fetal liver and adult bone marrow Blood 91 1998 3255 3262
57. C.P. Chiu W. Dragowska N.W. Kim H. Vaziri J. Yui T.E. Thomas C.B. Harley P.M. Lansdorp Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow Stem Cells 14 1996 239 248
58. P.M. Lansdorp Developmental changes in the function of hematopoietic stem cells Exp. Hematol. 23 1995 187 191
59. N. Rufer T.H. Brummendorf B. Chapuis C. Heig P.M. Lansdorp E. Roosnek Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation Blood 97 2001 575 577
60. N. Rufer W. Dragowska G. Thornbury E. Roosnek P.M. Lansdorp Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry Nat. Biotechnol. 16 1998 743 747
61. S.E. Ball F.M. Gibson S. Rizzo J.A. Tooze J.C.W. Marsh E.C. Gordonsmith Progressive telomere shortening in aplastic anemia Blood 91 1998 3582 3592
62. R. Notaro A. Cimmino D. Tabarini B. Rotoli L. Luzzatto In vivo telomere dynamics of human hematopoietic stem cells Proc. Natl. Acad. Sci. U. S. A. 94 1997 13782 13785
63. M. Akiyama O. Asai Y. Kuraishi M. Urashima Y. Hoshi H. Sakamaki H. Yabe T. Furukawa O. Yamada H. Mizoguchi H. Yamada Shortening of telomeres in recipients of both autologous and allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant. 25 2000 441 447
64. R. Wynn M. Cross C. Hatton A. Will L. Lashford T. Dexter N. Testa Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants Lancet 351 1998 178 181
65. R. Wynn I. Thornley M. Freedman E.F. Saunders Telomere shortening in leucocyte subsets of long-term survivors of allogeneic bone marrow transplantation Br. J. Haematol. 105 1999 997 1001
66. R.C. Allsopp S. Cheshier I.L. Weissman Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells J. Exp. Med. 193 2001 917 924
67. J.L. Abkowitz S.N. Catlin M.T. McCallie P. Guttorp Evidence that the number of hematopoietic stem cells per animal is conserved in mammals Blood 100 2002 2665 2667
68. B.E. Shepherd P. Guttorp P.M. Lansdorp J.L. Abkowitz Estimating human hematopoietic stem cell kinetics using granulocyte telomere lengths Exp. Hematol. 32 2004 1040 1050
69. J.V. Lopes J.M. Pacheco D. Dingli Acquired hematopoietic stem-cell disorders and mammalian size Blood 110 2007 4120 4122
70. T.B. Kirkwood S.N. Austad Why do we age? Nature 408 2000 233 238
71. L. Hayflick The limited in vitro lifetime of human diploid cell strains Exp. Cell Res. 37 1965 614 636
72. J. Campisi Replicative senescence: an old lives' tale? Cell 84 1996 497 500
73. E.H. Blackburn Telomeres and telomerase Keio J. Med. 49 2000 59 65
74. A.G. Bodnar M. Ouellette M. Frolkis S.E. Holt C.P. Chiu G.B. Morin C.B. Harley J.W. Shay S. Lichtsteiner W.E. Wright Extension of life-span by introduction of telomerase into normal human cells Science 279 1998 349 352
75. K.S. Joeng E.J. Song K.J. Lee J. Lee Long lifespan in worms with long telomeric DNA Nat. Genet. 36 2004 607 611
76. A. Nijnik L. Woodbine C. Marchetti S. Dawson T. Lambe C. Liu N.P. Rodrigues T.L. Crockford E. Cabuy A. Vindigni T. Enver J.I. Bell P. Slijepcevic C.C. Goodnow P.A. Jeggo R.J. Cornall DNA repair is limiting for haematopoietic stem cells during ageing Nature 447 2007 686 690
77. R.W. Hart R.B. Setlow Correlation between deoxyribonucleic acid excision-repair and life-span in a number of mammalian species Proc. Natl. Acad. Sci. U. S. A. 71 1974 2169 2173
78. V. Murray R. Holliday Increased error frequency of DNA polymerases from senescent human fibroblasts J. Mol. Biol. 146 1981 55 76
79. J. Campisi Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes Exp. Gerontol. 38 2003 5 11
80. C.M. Beausejour J. Campisi Ageing: balancing regeneration and cancer Nature 443 2006 404 405
81. G.M. Martin Frontiers of aging Science 294 2001 13
82. N.E. Sharpless R.A. DePinho Telomeres, stem cells, senescence, and cancer J. Clin. Invest. 113 2004 160 168
83. I.K. Park S.J. Morrison M.F. Clarke Bmi1, stem cells, and senescence regulation J. Clin. Invest. 113 2004 175 179
84. P.G. Pelicci Do tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence? J. Clin. Invest. 113 2004 4 7
85. J. Krishnamurthy M.R. Ramsey K.L. Ligon C. Torrice A. Koh S. Bonner-Weir N.E. Sharpless p16INK4a induces an age-dependent decline in islet regenerative potential Nature 443 2006 453 457
86. V. Janzen R. Forkert H.E. Fleming Y. Saito M.T. Waring D.M. Dombkowski T. Cheng R.A. DePinho N.E. Sharpless D.T. Scadden Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a Nature 443 2006 421 426
87. A.V. Molofsky S.G. Slutsky N.M. Joseph S. He R. Pardal J. Krishnamurthy N.E. Sharpless S.J. Morrison Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing Nature 443 2006 448 452
88. W.Y. Kim N.E. Sharpless The regulation of INK4/ARF in cancer and aging Cell 127 2006 265 275
89. D. Harman Aging: a theory based on free radical and radiation chemistry J. Gerontol. 11 1956 298 300
90. J. Sun J. Tower FLP recombinase-mediated induction of Cu/Zn-superoxide dismutase transgene expression can extend the life span of adult Drosophila melanogaster flies Mol. Cell. Biol. 19 1999 216 228
91. D.C. Wallace S. Melov Radicals r'aging Nat Genet 19 1998 105 106
92. D. Boffoli S.C. Scacco R. Vergari G. Solarino G. Santacroce S. Papa Decline with age of the respiratory chain activity in human skeletal muscle Biochim. Biophys. Acta 1226 1994 73 82
93. A. Trifunovic A. Wredenberg M. Falkenberg J.N. Spelbrink A.T. Rovio C.E. Bruder Y.M. Bohlooly S. Gidlof A. Oldfors R. Wibom J. Tornell H.T. Jacobs N.G. Larsson Premature ageing in mice expressing defective mitochondrial DNA polymerase Nature 429 2004 417 423
94. A.M. Cuervo J.F. Dice How do intracellular proteolytic systems change with age? Front. Biosci. 3 1998 D25 D43
95. A. Terman U.T. Brunk Lipofuscin Int. J. Biochem. Cell Biol. 36 2004 1400 1404
96. A.M. Cuervo J.F. Dice When lysosomes get old Exp. Gerontol. 35 2000 119 131
97. G. Barja A. Herrero Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals Faseb J. 14 2000 312 318
98. U.T. Brunk A. Terman The mitochondrial–lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis Eur. J. Biochem. 269 2002 1996 2002
99. C.B. Anfinsen Principles that govern the folding of protein chains Science 181 1973 223 230
100. H.S. Chan K.A. Dill Protein folding in the landscape perspective: chevron plots and non-Arrhenius kinetics Proteins 30 1998 2 33
101. K.A. Dill H.S. Chan From Levinthal to pathways to funnels Nat. Struct. Biol. 4 1997 10 19
102. K.A. Dill A.T. Phillips J.B. Rosen Protein structure and energy landscape dependence on sequence using a continuous energy function J. Comput. Biol. 4 1997 227 239
103. R.J. Ellis The molecular chaperone concept Semin. Cell Biol. 1 1990 1 9
104. J. Frydman Folding of newly translated proteins in vivo: the role of molecular chaperones Annu. Rev. Biochem. 70 2001 603 647
105. A.J. McClellan J. Frydman Molecular chaperones and the art of recognizing a lost cause Nat. Cell Biol. 3 2001 E51 E53
106. T. Grune T. Jung K. Merker K.J. Davies Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and ‘aggresomes’ during oxidative stress, aging, and disease Int. J. Biochem. Cell Biol. 36 2004 2519 2530
107. D. Poppek T. Grune [Protein oxidation and proteolysis during cellular senescence] Z. Gerontol. Geriatr. 37 2004 175 183
108. B.S. Berlett E.R. Stadtman Protein oxidation in aging, disease, and oxidative stress J. Biol. Chem. 272 1997 20313 20316
109. E.R. Stadtman B.S. Berlett Reactive oxygen-mediated protein oxidation in aging and disease Chem. Res. Toxicol. 10 1997 485 494
110. T. Finkel N.J. Holbrook Oxidants, oxidative stress and the biology of ageing Nature 408 2000 239 247
111. A. Gafni Altered protein metabolism in aging Annu. Rev. Gerontol. Geriatr. 10 1990 117 131
112. K.C. Wisser J.A. Schauerte D.T. Burke A. Galecki S. Chen R.A. Miller A. Gafni Mapping tissue-specific genes correlated with age-dependent changes in protein stability and function Arch. Biochem. Biophys. 432 2004 58 70
113. A. Gafni Structural modifications of proteins during aging J. Am. Geriatr. Soc. 45 1997 871 880
114. J.S. Butler S.N. Loh Kinetic partitioning during folding of the p53 DNA binding domain J. Mol. Biol. 350 2005 906 918
115. W.J. Welch Role of quality control pathways in human diseases involving protein misfolding Semin. Cell Dev. Biol. 15 2004 31 38
116. R. Guerois J.E. Nielsen L. Serrano Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations J. Mol. Biol. 320 2002 369 387
117. I. Mizuta W. Satake Y. Nakabayashi C. Ito S. Suzuki Y. Momose Y. Nagai A. Oka H. Inoko J. Fukae Y. Saito M. Sawabe S. Murayama M. Yamamoto N. Hattori M. Murata T. Toda Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease Hum. Mol. Genet. 15 2006 1151 1158
118. C. Holzmann R. Kruger A.M. Saecker I. Schmitt L. Schols K. Berger O. Riess Polymorphisms of the alpha-synuclein promoter: expression analyses and association studies in Parkinson's disease J. Neural Transm. 110 2003 67 76
119. R.E. Tanzi D.M. Kovacs T.W. Kim R.D. Moir S.Y. Guenette W. Wasco The gene defects responsible for familial Alzheimer's disease Neurobiol. Dis. 3 1996 159 168
120. G. de Haan W. Nijhof G. Van Zant Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity Blood 89 1997 1543 1550
121. G. de Haan G. Van Zant Genetic analysis of hemopoietic cell cycling in mice suggests its involvement in organismal life span FASEB J. 13 1999 707 713
122. H. Geiger G. Rennebeck G. Van Zant Regulation of hematopoietic stem cell aging in vivo by a distinct genetic element Proc. Natl. Acad. Sci. U. S. A. 102 2005 5102 5107
123. H. Geiger J.M. True G. de Haan G. Van Zant Age- and stage-specific regulation patterns in the hematopoietic stem cell hierarchy Blood 98 2001 2966 2972
124. S. KnaanShanzer S.F.F. Verlinden V.W. vanBeusechem D.W. VanBekkum D. Valerio Intrinsic potential of phenotypically defined human hemopoietic stem cells to self-renew in short-term in vitro cultures Exp. Hematol. 27 SEP 1999 1440 1450
125. S.J. Morrison D. Qian L. Jerabek B.A. Thiel I.K. Park P.S. Ford M.J. Kiel N.J. Schork I.L. Weissman M.F. Clarke A genetic determinant that specifically regulates the frequency of hematopoietic stem cells J. Immunol. 168 2002 635 642
126. R. Yuan C.M. Astle J. Chen D.E. Harrison Genetic regulation of hematopoietic stem cell exhaustion during development and growth Exp. Hematol. 33 2005 243 250
127. Y. Liang M. Jansen B. Aronow H. Geiger G. Van Zant The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in mice Nat. Genet. 39 2007 178 188
128. Y. Arimatsu Latexin: a molecular marker for regional specification in the neocortex Neurosci. Res. 20 1994 131 135
129. Y. Hatanaka Y. Uratani K. Takiguchi-Hayashi A. Omori K. Sato M. Miyamoto Y. Arimatsu Intracortical regionality represented by specific transcription for a novel protein, latexin Eur. J. Neurosci. 6 1994 973 982
130. Q. Liu L. Yu J. Gao Q. Fu J. Zhang P. Zhang J. Chen S. Zhao Cloning, tissue expression pattern and genomic organization of latexin, a human homologue of rat carboxypeptidase A inhibitor Mol. Biol. Rep. 27 2000 241 246
131. E. Normant M.P. Martres J.C. Schwartz C. Gros Purification, cDNA cloning, functional expression, and characterization of a 26-kDa endogenous mammalian carboxypeptidase inhibitor Proc. Natl. Acad. Sci. U. S. A. 92 1995 12225 12229
132. A. Aagaard P. Listwan N. Cowieson T. Huber T. Ravasi C.A. Wells J.U. Flanagan S. Kellie D.A. Hume B. Kobe J.L. Martin An inflammatory role for the mammalian carboxypeptidase inhibitor latexin: relationship to cystatins and the tumor suppressor TIG1 Structure (Camb) 13 2005 309 317
133. R. Garcia-Castellanos R. Bonet-Figueredo I. Pallares S. Ventura F.X. Aviles J. Vendrell F.X. Gomis-Rutha Detailed molecular comparison between the inhibition mode of A/B-type carboxypeptidases in the zymogen state and by the endogenous inhibitor latexin Cell. Mol. Life Sci. 62 2005 1996 2014
134. I. Pallares R. Bonet R. Garcia-Castellanos S. Ventura F.X. Aviles J. Vendrell F.X. Gomis-Ruth Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin Proc. Natl. Acad. Sci. U. S. A. 102 2005 3978 3983
135. D. Reverter C. Fernandez-Catalan R. Baumgartner R. Pfander R. Huber W. Bode J. Vendrell T.A. Holak F.X. Aviles Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2 Nat. Struct. Biol. 7 2000 322 328
136. Y. Uratani K. Takiguchi-Hayashi N. Miyasaka M. Sato M. Jin Y. Arimatsu Latexin, a carboxypeptidase A inhibitor, is expressed in rat peritoneal mast cells and is associated with granular structures distinct from secretory granules and lysosomes Biochem. J. 346 Pt 3 2000 817 826
137. I. Pallares C. Berenguer F.X. Aviles J. Vendrell S. Ventura Self-assembly of human latexin into amyloid-like oligomers BMC Struct. Biol. 7 2007 75
138. S. Rodziewicz-Motowidlo M. Wahlbom X. Wang J. Lagiewka R. Janowski M. Jaskolski A. Grubb Z. Grzonka Checking the conformational stability of cystatin C and its L68Q variant by molecular dynamics studies: why is the L68Q variant amyloidogenic? J. Struct. Biol. 154 2006 68 78
139. M. Mussap M. Plebani Biochemistry and clinical role of human cystatin C Crit. Rev. Clin. Lab. Sci. 41 2004 467 550
140. D.J. Newman Cystatin C Ann. Clin. Biochem. 39 2002 89 104
141. N.O. Fortunel H.H. Otu H.H. Ng J. Chen X. Mu T. Chevassut X. Li M. Joseph C. Bailey J.A. Hatzfeld A. Hatzfeld F. Usta V.B. Vega P.M. Long T.A. Libermann B. Lim Comment on “ ‘Stemness’: transcriptional profiling of embryonic and adult stem cells” and “a stem cell molecular signature” Science 302 2003 393 author reply 393
142. M. Ramalho-Santos S. Yoon Y. Matsuzaki R.C. Mulligan D.A. Melton “Stemness”: transcriptional profiling of embryonic and adult stem cells Science 298 2002 597 600
143. T. Kato T. Heike K. Okawa M. Haruyama K. Shiraishi M. Yoshimoto M. Nagato M. Shibata T. Kumada Y. Yamanaka H. Hattori T. Nakahata A neurosphere-derived factor, cystatin C, supports differentiation of ES cells into neural stem cells Proc. Natl. Acad. Sci. U. S. A. 103 2006 6019 6024
144. C.G. Glabe Common mechanisms of amyloid oligomer pathogenesis in degenerative disease Neurobiol. Aging 27 2006 570 575
145. Z.K. Mirnics K. Mirnics D. Terrano D.A. Lewis S.S. Sisodia N.F. Schor DNA microarray profiling of developing PS1-deficient mouse brain reveals complex and coregulated expression changes Mol. Psychiatry 8 2003 863 878
146. D.J. Selkoe The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease Trends Cell Biol. 8 1998 447 453
147. A. Nagai S. Kobayashi K. Shimode K. Imaoka N. Umegae S. Fujihara M. Nakamura No mutations in cystatin C gene in cerebral amyloid angiopathy with cystatin C deposition Mol. Chem. Neuropathol. 33 1998 63 78
148. S.A. Kaeser M.C. Herzig J. Coomaraswamy E. Kilger M.L. Selenica D.T. Winkler M. Staufenbiel E. Levy A. Grubb M. Jucker Cystatin C modulates cerebral beta-amyloidosis Nat. Genet. 39 2007 1437 1439
149. W. Mi M. Pawlik M. Sastre S.S. Jung D.S. Radvinsky A.M. Klein J. Sommer S.D. Schmidt R.A. Nixon P.M. Mathews E. Levy Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models Nat. Genet. 39 2007 1440 1442
150. E.M. Youssef X.Q. Chen E. Higuchi Y. Kondo G. Garcia-Manero R. Lotan J.P. Issa Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers Cancer Res. 64 2004 2411 2417
151. G. Callahan S.V. L. Hartmann D. Smith Characterization of a carboxypeptidase-A inhibitor identified by DD-PCR in primary ovarian tumors and cell lines Faseb J. f637 1999
152. O. Corticchiato J.F. Cajot M. Abrahamson S.J. Chan D. Keppler B. Sordat Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation Int. J. Cancer 52 1992 645 652
153. S.D. Konduri N. Yanamandra K. Siddique A. Joseph D.H. Dinh W.C. Olivero M. Gujrati G. Kouraklis A. Swaroop A.P. Kyritsis J.S. Rao Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cells Oncogene 21 2002 8705 8712
154. C.G. Huh K. Hakansson C.M. Nathanson U.P. Thorgeirsson N. Jonsson A. Grubb M. Abrahamson S. Karlsson Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene Mol. Pathol. 52 1999 332 340
155. J.P. Sokol W.P. Schiemann Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells Mol. Cancer Res. 2 2004 183 195